STAAR Surgical Company  

(Public, NASDAQ:STAA)   Watch this stock  
Find more results for Staar Surgical Co.�
6.76
+0.13 (1.96%)
After Hours: 6.76 0.00 (0.00%)
Jul 28, 4:55PM EDT  
NASDAQ real-time data - Disclaimer
Currency in USD
Range 6.51 - 6.81
52 week 4.98 - 9.21
Open 6.59
Vol / Avg. 31,718.00/93,935.00
Mkt cap 274.14M
P/E     -
Div/yield     -
EPS -0.31
Shares 40.19M
Beta 0.45
Inst. own 77%
Aug 3, 2016
Q2 2016 STAAR Surgical Co Earnings Call - 4:30PM EDT - Add to calendar
Aug 3, 2016
Q2 2016 STAAR Surgical Co Earnings Release - 4:00PM EDT - Add to calendar
Jul 7, 2016
STAAR Surgical Company Annual Shareholders Meeting (Estimated)
Jun 24, 2016
STAAR Surgical Co Annual Shareholders Meeting
Jun 10, 2016
STAAR Surgical Co at Jefferies Healthcare Conference
May 11, 2016
Q1 2016 STAAR Surgical Co Earnings Call - Webcast
May 11, 2016
Q1 2016 STAAR Surgical Co Earnings Release
More events from DailyFinance »    

Key stats and ratios

Q2 (Apr '16) 2016
Net profit margin -41.73% -8.47%
Operating margin -52.17% -6.92%
EBITD margin - -3.80%
Return on average assets -51.67% -10.72%
Return on average equity -83.58% -17.20%
Employees 360 -
CDP Score - -

Address

1911 Walker Ave
MONROVIA, CA 91016
United States - Map
+1-626-3037902 (Phone)
+1-626-3032962 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money

Description

STAAR Surgical Company designs, develops, manufactures and sells implantable lenses for the eye and delivery systems used to deliver the lenses into the eye. The Company operates in the ophthalmic surgical market segment. Its principal products are intraocular lenses (IOLs) used in cataract surgery and implantable collamer lenses (ICLs) used in refractive surgery. It makes lenses used across the world in corrective or refractive surgery, and makes lenses for use in surgery that treats cataracts. Its refractive surgery corrects the types of visual disorders that glasses or contact lenses have treated (myopia, hyperopia, astigmatism and presbyopia). Its refractive surgery corrects the types of visual disorders that glasses or contact lenses have treated (myopia, hyperopia, astigmatism and presbyopia). It sells its products in approximately 60 countries, with direct distribution in the United States, Canada, Japan and Spain, and independent distribution in the remainder of the world.

Officers and directors

Caren L. Mason President, Chief Executive Officer, Director
Age: 62
Bio & Compensation  - Reuters
Stephen P. Brown Chief Financial Officer, Vice President
Age: 56
Bio & Compensation  - Reuters
Hans-Martin Blickensdoerfer President - International Commercial Operations
Age: 51
Bio & Compensation  - Reuters
Deborah J. Andrews Chief Accounting Officer, Vice President
Age: 57
Bio & Compensation  - Reuters
Samuel J. Gesten Vice President - Business Development, General Counsel, Corporate Compliance Officer and Secretary
Age: 54
Bio & Compensation  - Reuters
James E. Francese Vice President - Global Marketing
Age: 51
Bio & Compensation  - Reuters
William Walter Goodmen Vice President - Global Human Resources
Age: 60
Bio & Compensation  - Reuters
Jon K. Hayashida Vice President of Global Clinical and Medical Affairs
Bio & Compensation  - Reuters
Philippe Subrin Vice President-ICL Manufacturing
Age: 51
Bio & Compensation  - Reuters
Keith Holliday Ph.D. Vice President - Research & Development
Bio & Compensation  - Reuters